Dual Antiplatelet Treatment up to 72 Hours After Ischemic Stroke Stratified by Risk Profile: A Post Hoc Analysis

被引:0
|
作者
Zhang, Yanli [1 ,2 ]
Wang, Xuan [1 ,2 ]
Gao, Ying [1 ,2 ]
Chen, Weiqi [1 ,2 ]
Johnston, S. Claiborne [3 ]
Amarenco, Pierre [4 ,5 ,6 ]
Bath, Philip M. [7 ]
Yan, Hongyi [1 ,2 ]
Wang, Tingting [1 ,2 ]
Yang, Yingying [1 ,2 ]
Zhou, Qi [1 ,2 ]
Wang, Mengxing [1 ,2 ]
Jing, Jing [1 ,2 ]
Wang, Chunjuan [1 ,2 ]
Wang, Yongjun [1 ,2 ,8 ,9 ,10 ]
Wang, Yilong [1 ,2 ,8 ,9 ,11 ,12 ,13 ]
Pan, Yuesong [1 ,2 ]
机构
[1] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, 119 S 4th Ring W Rd, Beijing 100070, Peoples R China
[2] China Natl Clin Res Ctr Neurol Dis, Beijing, Peoples R China
[3] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA
[4] Univ Paris, Bichat Hosp, APHP, INSERM LVTS U1148,Dept Neurol, Paris, France
[5] Univ Paris, Bichat Hosp, APHP, Stroke Ctr,INSERM LVTS U1148, Paris, France
[6] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[7] Univ Nottingham, Mental Hlth & Clin Neurosci, Stroke Trials Unit, Nottingham, England
[8] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing, Peoples R China
[9] Natl Ctr Neurol Disorders, Beijing, Peoples R China
[10] Chinese Acad Med Sci, Res Unit Artificial Intelligence Cerebrovascular D, Beijing, Peoples R China
[11] Chinese Inst Brain Res, Beijing, Peoples R China
[12] Capital Med Univ, Beijing Lab Oral Hlth, Beijing, Peoples R China
[13] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China
基金
国家重点研发计划; 中国国家自然科学基金;
关键词
aspirin; clopidogrel; risk factors; stroke; SECONDARY PREVENTION; CHINESE GUIDELINES; ACTIVE METABOLITE; MINOR STROKE; CLOPIDOGREL; ATTACK; PREDICTS; RESPONSIVENESS; THERAPY; EVENTS;
D O I
10.1161/STROKEAHA.124.049246
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND: Risk profile of recurrence may influence the effect of antiplatelet therapy. This study aimed to evaluate the efficacy and safety of clopidogrel-aspirin initiated within 72 hours after symptom onset for acute mild stroke or high-risk transient ischemic attack stratified by risk profile. METHODS: This is a secondary post hoc analysis of the INSPIRES (Intensive Statin and Antiplatelet Therapy for Acute High-risk Intracranial or Extracranial Atherosclerosis) randomized clinical trial that enrolled patients 35 to 80 years old with acute mild ischemic stroke or high-risk transient ischemic attack between 2018 and 2022. Patients were stratified into different groups based on the Essen Stroke Risk Score (ESRS) and modified ESRS. The primary efficacy outcome was any new stroke within 90 days. The primary safety outcome was moderate-to-severe bleeding within 90 days. RESULTS: Among 6100 patients (3050 each in the clopidogrel-aspirin group and aspirin group), the median age was 65 years (interquartile range, 57-71 years), and 3915 (64.2%) were male. Clopidogrel-aspirin was associated with a reduced risk of new stroke in patients with an ESRS of <3 (hazard ratio [HR], 0.67 [95% CI, 0.52-0.86]), but not in those with an ESRS of >= 3 (HR, 0.92 [95% CI, 0.72-1.18]), compared with aspirin (P-interaction=0.07). Similar results were found in patients stratified by modified ESRS (modified ESRS <6 in male and <5 in female: HR, 0.68 [95% CI, 0.55-0.83]; modified ESRS >= 6 in male and >= 5 in female: HR, 1.14 [95% CI, 0.82-1.59]; P-interaction=0.01). The association between antiplatelet therapy and the moderate-to-severe bleeding did not differ across risk profile subgroups (ESRS of <3: HR, 1.35 [95% CI, 0.54-3.35]; ESRS of >= 3: HR, 3.21 [95% CI, 1.18-8.78]; P-interaction=0.21; modified ESRS of <6 in male and <5 in female: HR, 1.96 [95% CI, 0.88-4.36]; modified ESRS of >= 6 in male and >= 5 in female: HR, 2.27 [95% CI, 0.70-7.39]; P-interaction=0.85). CONCLUSIONS: This post hoc analysis of the INSPIRES trial showed that patients with a low level of risk profile assessed by ESRS received greater benefit from clopidogrel-aspirin initiated within 72 hours after symptom onset than aspirin alone.
引用
收藏
页码:46 / 55
页数:10
相关论文
共 50 条
  • [31] Risk Profile of Patients after Ischemic Stroke - Data Analysis from the IKTA Register
    Kalita, Z.
    Brabec, P.
    Svancara, J.
    Vohanka, S.
    Jura, R.
    Mikulik, R.
    Kuliha, M.
    Neumann, J.
    Rajner, J.
    Kral, M.
    Polivka, J.
    Vaclavik, D.
    Talab, R.
    Latta, J.
    Skoda, O.
    Barteys, M.
    CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 2013, 76 (03) : 343 - 349
  • [32] Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis
    Foschi, Matteo
    Ornello, Raffaele
    D'Anna, Lucio
    De Matteis, Eleonora
    De Santis, Federico
    Barone, Valentina
    Viola, Marilina
    Mosconi, Maria Giulia
    Rosin, Diletta
    Romoli, Michele
    Tassinari, Tiziana
    Cenciarelli, Silvia
    Censori, Bruno
    Zedde, Marialuisa
    Diomedi, Marina
    Petruzzellis, Marco
    Inchingolo, Vincenzo
    Cappellari, Manuel
    Candelaresi, Paolo
    Bavaro, Alessandra
    Cavallini, Anna
    Piscaglia, Maria Grazia
    Terruso, Valeria
    Pezzini, Alessandro
    Frisullo, Giovanni
    Muscia, Francesco
    Zini, Andrea
    Leone, Ruggiero
    Palmieri, Carmela
    Cupini, Letizia Maria
    Marcon, Michela
    Tassi, Rossana
    Sanzaro, Enzo
    Papiri, Giulio
    Viticchi, Giovanna
    Orsucci, Daniele
    Falcou, Anne
    Diamanti, Susanna
    Tarletti, Roberto
    Nencini, Patrizia
    Rota, Eugenia
    Sepe, Federica Nicoletta
    Caputi, Luigi
    Volpi, Gino
    La Spada, Salvatore
    Beccia, Mario
    Mastrangelo, Vincenzo
    Invernizzi, Paolo
    Pelliccioni, Giuseppe
    De Angelis, Maria Vittoria
    INTERNATIONAL JOURNAL OF STROKE, 2025, 20 (04) : 438 - 449
  • [33] Dual Antiplatelet Versus Alteplase for Early Neurologic Deterioration in Minor Stroke With Versus Without Large Vessel Occlusion: Prespecified Post Hoc Analysis of the ARAMIS Trial
    Cui, Yu
    He, Chao
    Li, Zi-Ang
    Wang, Yue
    Chen, Hui-Sheng
    STROKE, 2024, 55 (11) : 2590 - 2598
  • [34] Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort
    Foschi, Matteo
    D'Anna, Lucio
    De Matteis, Eleonora
    De Santis, Federico
    Romoli, Michele
    Tassinari, Tiziana
    Saia, Valentina
    Cenciarelli, Silvia
    Bedetti, Chiara
    Padiglioni, Chiara
    Censori, Bruno
    Puglisi, Valentina
    Vinciguerra, Luisa
    Guarino, Maria
    Barone, Valentina
    Zedde, Marialuisa
    Grisendi, Ilaria
    Diomedi, Marina
    Bagnato, Maria Rosaria
    Petruzzellis, Marco
    Mezzapesa, Domenico Maria
    Di Viesti, Pietro
    Inchingolo, Vincenzo
    Cappellari, Manuel
    Zivelonghi, Cecilia
    Candelaresi, Paolo
    Andreone, Vincenzo
    Rinaldi, Giuseppe
    Bavaro, Alessandra
    Cavallini, Anna
    Moraru, Stefan
    Piscaglia, Maria Grazia
    Terruso, Valeria
    Mannino, Marina
    Pezzini, Alessandro
    Frisullo, Giovanni
    Muscia, Francesco
    Paciaroni, Maurizio
    Mosconi, Maria Giulia
    Zini, Andrea
    Leone, Ruggiero
    Palmieri, Carmela
    Cupini, Letizia Maria
    Marcon, Michela
    Tassi, Rossana
    Sanzaro, Enzo
    Papiri, Giuli
    Paci, Cristina
    Viticchi, Giovanna
    Orsucci, Daniele
    STROKE, 2025, 56 (02) : 305 - 317
  • [35] Shoulder pain after recent stroke (SPARS): hemiplegic shoulder pain incidence within 72 hours post-stroke and 8-10 week follow-up (NCT 02574000)
    Nadler, Martine
    Pauls, Mathilde
    Cluckie, Gillian
    Moynihan, Barry
    Pereira, Anthony C.
    PHYSIOTHERAPY, 2020, 107 : 142 - 149
  • [36] Change in Smoking Behavior and Outcome After Ischemic Stroke: Post-Hoc Analysis of the SPS3 Trial
    Anadani, Mohammad
    Turan, Tanya N.
    Yaghi, Shadi
    Spiotta, Alejandro M.
    Gory, Benjamin
    Sharma, Richa
    Sheth, Kevin N.
    de Havenon, Adam
    STROKE, 2023, 54 (04) : 921 - 927
  • [37] Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort
    Ornello, Raffaele
    Foschi, Matteo
    De Santis, Federico
    Romoli, Michele
    Tassinari, Tiziana
    Saia, Valentina
    Cenciarelli, Silvia
    Bedetti, Chiara
    Padiglioni, Chiara
    Censori, Bruno
    Puglisi, Valentina
    Vinciguerra, Luisa
    Guarino, Maria
    Barone, Valentina
    Zedde, Marialuisa
    Grisendi, Ilaria
    Diomedi, Marina
    Bagnato, Maria Rosaria
    Petruzzellis, Marco
    Mezzapesa, Domenico Maria
    Di Viesti, Pietro
    Inchingolo, Vincenzo
    Cappellari, Manuel
    Zivelonghi, Cecilia
    Candelaresi, Paolo
    Andreone, Vincenzo
    Rinaldi, Giuseppe
    Bavaro, Alessandra
    Cavallini, Anna
    Moraru, Stefan
    Querzani, Pietro
    Terruso, Valeria
    Mannino, Marina
    Pezzini, Alessandro
    Frisullo, Giovanni
    Muscia, Francesco
    Paciaroni, Maurizio
    Mosconi, Maria Giulia
    Zini, Andrea
    Leone, Ruggiero
    Palmieri, Carmela
    Cupini, Letizia Maria
    Marcon, Michela
    Tassi, Rossana
    Sanzaro, Enzo
    Paci, Cristina
    Viticchi, Giovanna
    Orsucci, Daniele
    Falcou, Anne
    Beretta, Simone
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2024, 13 (16):
  • [38] Dual antiplatelet therapy with ticagrelor vs clopidogrel in patients with TIA or minor stroke with or without symptomatic carotid artery stenosis: a post hoc analysis of the CHANCE-2 trial
    Xie, Xuewei
    Jing, Jing
    Wang, Anxin
    Xu, Qin
    Zhao, Xingquan
    Lin, Jinxi
    Chen, Pan
    Jiang, Yong
    Wang, Yilong
    Li, Hao
    Meng, Xia
    Wang, Yongjun
    STROKE AND VASCULAR NEUROLOGY, 2025,
  • [39] Hyperglycemic control in acute ischemic stroke patients undergoing endovascular treatment: post hoc analysis of the Stroke Hyperglycemia Insulin Network Effort trial
    Bains, Navpreet K.
    Huang, Wei
    French, Brandi R.
    Siddiq, Farhan
    Gomez, Camilo R.
    Qureshi, Adnan, I
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2023, 15 (04) : 370 - 374
  • [40] 'Ticagrelor alone vs. dual antiplatelet therapy from 1 month after drug-eluting coronary stenting among patients with STEMI': a post hoc analysis of the randomized GLOBAL LEADERS trial
    Gamal, Amr S.
    Hara, Hironori
    Tomaniak, Mariusz
    Lunardi, Mattia
    Gao, Chao
    Ono, Masafumi
    Kawashima, Hideyuki
    Juni, Peter
    Vranckx, Pascal
    Windecker, Stephan
    Hamm, Christian
    Steg, Philippe Gabriel
    Onuma, Yoshinobu
    Serruys, Patrick W.
    EUROPEAN HEART JOURNAL-ACUTE CARDIOVASCULAR CARE, 2021, 10 (07) : 756 - 773